Associate Director, Safety Epidemiology and Benefit RiskNovavax, United States
Disclosure information not submitted.
Effectiveness of recombinant herpes zoster vaccine by immune status and prior receipt of live zoster vaccine in Medicare enrollees, 2018-2019
Wednesday, August 28, 20249:15 AM – 9:30 AM CEST